Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Other 1

Conditions

Lymphoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Rectal Neoplasms 1Pain 1Neoplasms 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphedema 1Glioma 1Fallopian Tube Neoplasms 1Carcinoma in Situ 1Brenner Tumor 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Abnormalities, Radiation-Induced 1

Interventions

Cisplatin 47Radiotherapy 37Fluorouracil 23Cetuximab 17pembrolizumab 11Carboplatin 11Paclitaxel 8Docetaxel 8Radiotherapy, Intensity-Modulated 6Chemotherapy, Adjuvant 6Surgical Procedures, Operative 5Standard of Care 5nimotuzumab 4Methotrexate 4Gabapentin 4Drug Therapy 4Afatinib 4Radiotherapy, Conformal 3Radiation 3Porfiromycin 3Nivolumab 3Neoadjuvant Therapy 3Fibroblast Growth Factor 7 3Bleomycin 3zalutumumab 2sargramostim 2epacadostat 2Tranexamic Acid 2Tirapazamine 2Pilocarpine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Head and Neck Neoplasms × Methods × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

NCT01716780 2012-10-30

Pain: Screen and Treat

Royal Marsden NHS Foundation Trust

Phase 3 Unknown
156 enrolled
Head & Neck

Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡